About the project


V.A. Cure is a European MSCA-ITN network aiming to uncover core mechanisms of initiation and maintenance of Vascular Anomalies (VAs) and to leverage this information for establishing novel therapeutic strategies. The network consortium consists of 7 academic laboratories and 2 companies from across Europe, and is supported by 9 partner organisations.
The 14 Early Stage Researchers (ESRs) will be a part of  the unique international PhD program, consisting of an individual research project, the network’s training programme, intersectoral secondments and outreach activities. Project goal is to  ensure a comprehensive perception of the research and drug/technology development in pharma industry/biotech and academia.

Our student @Tala_AlTabosh at @BaillySabine lab is establishing a cellular model for #HHT by isolating endothelial colony-forming cells from the blood of HHT patients. With this minimally invasive procedure, patient-derived endothelial cells have become more accessible! #msca https://t.co/PbN1AAxYP5

VACure1 photo

Project has received funding from the European Union’s Horizon 2020 research and innovation programme under the Marie Skłodowska-Curie grant agreement No 814316